Debt-to-equity of Immuneering Corp from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Immuneering Corp quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Immuneering Corp Debt-to-equity for the quarter ending 30 Sep 2025 was 13%, a 11% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Immuneering Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 13% -2% -11% 30 Sep 2025
Q2 2025 25% +12% +101% 30 Jun 2025
Q1 2025 20% +10% +91% 31 Mar 2025
Q4 2024 17% +7% +70% 31 Dec 2024
Q3 2024 15% +5% +48% 30 Sep 2024
Q2 2024 12% +2% +25% 30 Jun 2024
Q1 2024 11% +1% +14% 31 Mar 2024
Q4 2023 10% +2% +26% 31 Dec 2023
Q3 2023 10% +3% +39% 30 Sep 2023
Q2 2023 10% +4% +76% 30 Jun 2023
Q1 2023 9% +2% +29% 31 Mar 2023
Q4 2022 8% 31 Dec 2022
Q3 2022 7% 30 Sep 2022
Q2 2022 6% 30 Jun 2022
Q1 2022 7% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.